# reload+after+2024-01-22 06:26:39.179515
address1§1655 Roberts Boulevard N.W.
city§Kennesaw
state§GA
zip§30144
country§United States
phone§770 419 3355
website§https://artivion.com
industry§Medical Devices
industryKey§medical-devices
industryDisp§Medical Devices
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent and graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
fullTimeEmployees§1300
companyOfficers§[{'maxAge': 1, 'name': 'Mr. James Patrick Mackin', 'age': 56, 'title': 'Chairman, President & CEO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1629083, 'exercisedValue': 287729, 'unexercisedValue': 123232}, {'maxAge': 1, 'name': 'Ms. Jean F. Holloway Esq.', 'age': 66, 'title': 'Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 636724, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John E. Davis', 'age': 58, 'title': 'Senior Vice President of Global Sales & Marketing', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 609913, 'exercisedValue': 0, 'unexercisedValue': 16441}, {'maxAge': 1, 'name': 'Mr. David Ashley Lee CPA', 'age': 58, 'title': 'Executive Vice President of Finance', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 825428, 'exercisedValue': 0, 'unexercisedValue': 69225}, {'maxAge': 1, 'name': 'Dr. Marshall S. Stanton M.D.', 'age': 66, 'title': 'Senior VP of Clinical Research & Chief Medical Officer', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 615546, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Lance E. Berry CPA', 'age': 51, 'title': 'Executive VP & CFO', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Amy D. Horton CPA', 'age': 53, 'title': 'VP & Chief Accounting Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matthew A. Getz', 'age': 53, 'title': 'VP & Chief Human Resources Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Robert C. Thomson', 'title': 'VP of Research & Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§3
boardRisk§4
compensationRisk§3
shareHolderRightsRisk§4
overallRisk§3
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
exDividendDate§1449619200
payoutRatio§0.0
beta§1.59
priceToSalesTrailing12Months§2.0238423
currency§USD
dateShortInterest§1702598400
forwardEps§-0.02
pegRatio§-11.38
lastDividendValue§0.03
lastDividendDate§1449619200
exchange§NYQ
quoteType§EQUITY
shortName§Artivion, Inc.
longName§Artivion, Inc.
firstTradeDateEpochUtc§729527400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§1f6f2d83-884e-3d6e-bb69-1accca578e1a
messageBoardId§finmb_27212
gmtOffSetMilliseconds§-18000000
targetHighPrice§28.0
targetLowPrice§20.0
targetMeanPrice§24.15
targetMedianPrice§25.0
recommendationMean§1.4
recommendationKey§strong_buy
numberOfAnalystOpinions§5
quickRatio§2.215
grossMargins§0.64453006
ebitdaMargins§0.09633
trailingPegRatio§None
